Evaluation in clinical practice of the fluorescent amoebic antibody test

Open Access
Publisher Website
Google Scholar
Abstract
Serum fluorescent antibody levels against Entamoeba histolytica were determined in patients with amoebic infection and in control cases. Titres of 1: 64 or above were obtained only in cases of active or recent amoebic infection, and were recorded in 75·0% of intestinal cases and in 95·2% of extraintestinal cases. Titres given by symptomless carriers of Entamoeba histolytica, though not exceeding 1: 32, were proportionately higher than those obtained in normal subjects or in patients with non-amoebic disorders.